BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21156802)

  • 21. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
    Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
    Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E; Boulay F; Barral S; Rabiet MJ
    Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.
    Braun L; Christophe T; Boulay F
    J Biol Chem; 2003 Feb; 278(6):4277-85. PubMed ID: 12464600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valine-286 residue in the third intracellular loop of the cholecystokinin 2 receptor exerts a pivotal role in cholecystokinin 2 receptor mediated intracellular signal transduction in human colon cancer cells.
    Yu HG; Schäfer H; Mergler S; Müerköster S; Cramer T; Höcker M; Herzig KH; Schmidt WE; Schmitz F
    Cell Signal; 2005 Dec; 17(12):1505-15. PubMed ID: 15951156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors.
    Lin FT; Chen W; Shenoy S; Cong M; Exum ST; Lefkowitz RJ
    Biochemistry; 2002 Aug; 41(34):10692-9. PubMed ID: 12186555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute depletion of plasma membrane phosphatidylinositol 4,5-bisphosphate impairs specific steps in endocytosis of the G-protein-coupled receptor.
    Tóth DJ; Tóth JT; Gulyás G; Balla A; Balla T; Hunyady L; Várnai P
    J Cell Sci; 2012 May; 125(Pt 9):2185-97. PubMed ID: 22357943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL; Koehler JA; Yusta B; Drucker DJ
    J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
    Charest PG; Bouvier M
    J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of beta-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization.
    Simaan M; Bédard-Goulet S; Fessart D; Gratton JP; Laporte SA
    Cell Signal; 2005 Sep; 17(9):1074-83. PubMed ID: 15993749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
    Wei H; Ahn S; Barnes WG; Lefkowitz RJ
    J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
    Jones BW; Hinkle PM
    J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential requirements of arrestin-3 and clathrin for ligand-dependent and -independent internalization of human G protein-coupled receptor 40.
    Qian J; Wu C; Chen X; Li X; Ying G; Jin L; Ma Q; Li G; Shi Y; Zhang G; Zhou N
    Cell Signal; 2014 Nov; 26(11):2412-23. PubMed ID: 25038452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors following clathrin-mediated endocytosis.
    Liang W; Curran PK; Hoang Q; Moreland RT; Fishman PH
    J Cell Sci; 2004 Feb; 117(Pt 5):723-34. PubMed ID: 14734649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
    Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor.
    Déry O; Thoma MS; Wong H; Grady EF; Bunnett NW
    J Biol Chem; 1999 Jun; 274(26):18524-35. PubMed ID: 10373461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the fate of type I angiotensin receptor after biased activation.
    Szakadáti G; Tóth AD; Oláh I; Erdélyi LS; Balla T; Várnai P; Hunyady L; Balla A
    Mol Pharmacol; 2015 Jun; 87(6):972-81. PubMed ID: 25804845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
    Berna MJ; Tapia JA; Sancho V; Jensen RT
    Curr Opin Pharmacol; 2007 Dec; 7(6):583-92. PubMed ID: 17997137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.